CHICAGO — The EyeArt artificial intelligence system for diabetic retinopathy screening demonstrated nearly 96% sensitivity for the detection of moderate or higher nonproliferative diabetic retinopathy, according to a speaker here.
“EyeArt AI system compared favorably with clinical reference standard four-field stereoscopic images. … It is therefore useful for the detection of referable DR in patients with diabetes. This can enable point-of-care screening,” Jennifer I. Lim, MD, said at the American Society of Retina Specialists annual meeting.
In the prospective study across
Anupam Ghose, a physician by training, was diagnosed with Type 2 Diabetes Mellitus (T2DM) in 2017. After the diagnosis of T2DM, he followed a low carbohydrate high fat diet and reversed his T2DM within a year. Now he has one main goal in life. Yes, it is to make people understand that the conventional method of treating T2DM is not beneficial. The best way to reverse T2DM is through diet and lifestyle modification. He decided to help people suffering from T2DM in their new journey by offering consultations and working together with them in order to achieve a T2DM free life.